ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Coker, R.
Right arrow Articles by Laurent, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coker, R.
Right arrow Articles by Laurent, G.
Eur Respir J 1998; 11: 1218-1221
Copyright © ERS Journals Ltd 1998

Original Articles

Pulmonary fibrosis: cytokines in the balance

RK Coker and GJ Laurent

Pulmonary fibrosis can complicate diverse pulmonary and systemic pathologies. In many cases the underlying cause remains unidentified. Mortality from the disease is increasing steadily in the UK and USA. The clinical features are well-described, but patients frequently present at an advanced stage, and current treatments have not improved the poor prognosis. There is a compelling need to identify the fibrotic process earlier and to develop new therapeutic agents. Increased collagen deposition is central to the pathology and interest over the last decade has focused on the role of cytokines in this process. These polypeptide mediators are believed to be released from both circulating inflammatory and resident lung cells in response to endothelial and epithelial injury. Key cytokines currently implicated in the fibrotic process are transforming growth factor-beta, tumour necrosis factor-alpha and endothelin-1. This article outlines the evidence implicating these mediators in the pathogenesis of pulmonary fibrosis and also considers the possible role of cytokines with antifibrotic effects, such as interferon-gamma. The "balance" of positively and negatively regulating cytokines is discussed, and the potential for interaction with other factors including viruses, hormones and altered antioxidant status is also considered. Finally, potential novel therapeutic approaches are discussed, together with suggestions for future studies and clinical trials. As the outcomes of different avenues of research over the last ten years are brought together, it is clear that there is now a hitherto unrivalled opportunity to begin to tackle the treatment of this devastating disease.


This article has been cited by other articles:


Home page
 Mol. Cell. Biol.Home page
W. R. Coward, K. Watts, C. A. Feghali-Bostwick, A. Knox, and L. Pang
Defective Histone Acetylation Is Responsible for the Diminished Expression of Cyclooxygenase 2 in Idiopathic Pulmonary Fibrosis
Mol. Cell. Biol., August 1, 2009; 29(15): 4325 - 4339.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
M Kishi, Y Miyazaki, T Jinta, H Furusawa, Y Ohtani, N Inase, and Y Yoshizawa
Pathogenesis of cBFL in common with IPF? Correlation of IP-10/TARC ratio with histological patterns
Thorax, September 1, 2008; 63(9): 810 - 816.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
G. J. Laurent, R. J. McAnulty, M. Hill, and R. Chambers
Escape from the Matrix: Multiple Mechanisms for Fibroblast Activation in Pulmonary Fibrosis
Proceedings of the ATS, April 15, 2008; 5(3): 311 - 315.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
A. Clement and E. Eber
Interstitial lung diseases in infants and children
Eur. Respir. J., March 1, 2008; 31(3): 658 - 666.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
T J Williams and J W Wilson
Challenges in pulmonary fibrosis: 7 {middle dot} Novel therapies and lung transplantation
Thorax, March 1, 2008; 63(3): 277 - 284.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
M. Arras, J. Louahed, V. Simoen, V. Barbarin, P. Misson, S. van den Brule, M. Delos, L. Knoops, J.-C. Renauld, D. Lison, et al.
B Lymphocytes Are Critical for Lung Fibrosis Control and Prostaglandin E2 Regulation in IL-9 Transgenic Mice
Am. J. Respir. Cell Mol. Biol., May 1, 2006; 34(5): 573 - 580.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
P. Pignatti, G. Brunetti, D. Moretto, M.-R. Yacoub, M. Fiori, B. Balbi, A. Balestrino, G. Cervio, S. Nava, and G. Moscato
Role of the Chemokine Receptors CXCR3 and CCR4 in Human Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med., February 1, 2006; 173(3): 310 - 317.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. Hinton, L. Mellow, A. J. Halayko, A. Gutsol, and S. Dakshinamurti
Hypoxia induces hypersensitivity and hyperreactivity to thromboxane receptor agonist in neonatal pulmonary arterial myocytes
Am J Physiol Lung Cell Mol Physiol, February 1, 2006; 290(2): L375 - L384.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
S. Zanotti, T. Negri, C. Cappelletti, P. Bernasconi, E. Canioni, C. Di Blasi, E. Pegoraro, C. Angelini, P. Ciscato, A. Prelle, et al.
Decorin and biglycan expression is differentially altered in several muscular dystrophies
Brain, November 1, 2005; 128(11): 2546 - 2555.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
D. A. Gorvy, S. E. Herrick, M. Shah, and M. W.J. Ferguson
Experimental Manipulation of Transforming Growth Factor-{beta} Isoforms Significantly Affects Adhesion Formation in a Murine Surgical Model
Am. J. Pathol., October 1, 2005; 167(4): 1005 - 1019.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
E. Sokolova, Z. Grishina, F. Buhling, T. Welte, and G. Reiser
Protease-activated receptor-1 in human lung fibroblasts mediates a negative feedback downregulation via prostaglandin E2
Am J Physiol Lung Cell Mol Physiol, May 1, 2005; 288(5): L793 - L802.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
K. A. Keogh, J. Standing, G. C. Kane, A. Terzic, and A. H. Limper
Angiotensin II antagonism fails to ameliorate bleomycin-induced pulmonary fibrosis in mice
Eur. Respir. J., April 1, 2005; 25(4): 708 - 714.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
E. Cavarra, F. Carraro, S. Fineschi, A. Naldini, B. Bartalesi, A. Pucci, and G. Lungarella
Early response to bleomycin is characterized by different cytokine and cytokine receptor profiles in lungs
Am J Physiol Lung Cell Mol Physiol, December 1, 2004; 287(6): L1186 - L1192.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
R. J. Hodges, R. G. Jenkins, C. P.D. Wheeler-Jones, D. M. Copeman, S. E. Bottoms, G. J. Bellingan, C. B. Nanthakumar, G. J. Laurent, S. L. Hart, M. L. Foster, et al.
Severity of Lung Injury in Cyclooxygenase-2-Deficient Mice Is Dependent on Reduced Prostaglandin E2 Production
Am. J. Pathol., November 1, 2004; 165(5): 1663 - 1676.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
T. Inoue, S. Fujishima, E. Ikeda, O. Yoshie, N. Tsukamoto, S. Aiso, N. Aikawa, A. Kubo, K. Matsushima, and K. Yamaguchi
CCL22 and CCL17 in rat radiation pneumonitis and in human idiopathic pulmonary fibrosis
Eur. Respir. J., July 1, 2004; 24(1): 49 - 56.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
V. Barbarin, M. Arras, P. Misson, M. Delos, B. McGarry, S. H. Phan, D. Lison, and F. Huaux
Characterization of the Effect of Interleukin-10 on Silica-Induced Lung Fibrosis in Mice
Am. J. Respir. Cell Mol. Biol., July 1, 2004; 31(1): 78 - 85.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
C. Jakubzick, E. S. Choi, K. J. Carpenter, S. L. Kunkel, H. Evanoff, F. J. Martinez, K. R. Flaherty, G. B. Toews, T. V. Colby, W. D. Travis, et al.
Human Pulmonary Fibroblasts Exhibit Altered Interleukin-4 and Interleukin-13 Receptor Subunit Expression in Idiopathic Interstitial Pneumonia
Am. J. Pathol., June 1, 2004; 164(6): 1989 - 2001.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
G. Raghu, K. K. Brown, W. Z. Bradford, K. Starko, P. W. Noble, D. A. Schwartz, T. E. King Jr., and the Idiopathic Pulmonary Fibrosis Study Group
A Placebo-Controlled Trial of Interferon Gamma-1b in Patients with Idiopathic Pulmonary Fibrosis
N. Engl. J. Med., January 8, 2004; 350(2): 125 - 133.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
M. Ghosh, A. Stewart, D. E. Tucker, J. V. Bonventre, R. C. Murphy, and C. C. Leslie
Role of Cytosolic Phospholipase A2 in Prostaglandin E2 Production by Lung Fibroblasts
Am. J. Respir. Cell Mol. Biol., January 1, 2004; 30(1): 91 - 100.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Zhang-Hoover and J. Stein-Streilein
Tolerogenic APC Generate CD8+ T Regulatory Cells That Modulate Pulmonary Interstitial Fibrosis
J. Immunol., January 1, 2004; 172(1): 178 - 185.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
Y. P. Moodley, N. L. A. Misso, A. K. Scaffidi, M. Fogel-Petrovic, R. J. McAnulty, G. J. Laurent, P. J. Thompson, and D. A. Knight
Inverse Effects of Interleukin-6 on Apoptosis of Fibroblasts from Pulmonary Fibrosis and Normal Lungs
Am. J. Respir. Cell Mol. Biol., October 1, 2003; 29(4): 490 - 498.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
J. W. Card, W. J. Racz, J. F. Brien, S. B. Margolin, and T. E. Massey
Differential Effects of Pirfenidone on Acute Pulmonary Injury and Ensuing Fibrosis in the Hamster Model of Amiodarone-Induced Pulmonary Toxicity
Toxicol. Sci., September 1, 2003; 75(1): 169 - 180.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
A. Bergeron, P. Soler, M. Kambouchner, P. Loiseau, B. Milleron, D. Valeyre, A.J. Hance, and A. Tazi
Cytokine profiles in idiopathic pulmonary fibrosis suggest an important role for TGF-{beta} and IL-10
Eur. Respir. J., July 1, 2003; 22(1): 69 - 76.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
Y. P. Moodley, A. K. Scaffidi, N. L. Misso, C. Keerthisingam, R. J. McAnulty, G. J. Laurent, S. E. Mutsaers, P. J. Thompson, and D. A. Knight
Fibroblasts Isolated from Normal Lungs and Those with Idiopathic Pulmonary Fibrosis Differ in Interleukin-6/gp130-Mediated Cell Signaling and Proliferation
Am. J. Pathol., July 1, 2003; 163(1): 345 - 354.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
C. Jakubzick, E. S. Choi, S. L. Kunkel, B. H. Joshi, R. K. Puri, and C. M. Hogaboam
Impact of Interleukin-13 Responsiveness on the Synthetic and Proliferative Properties of Th1- and Th2-Type Pulmonary Granuloma Fibroblasts
Am. J. Pathol., May 1, 2003; 162(5): 1475 - 1486.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
F. Demayo, P. Minoo, C. G. Plopper, L. Schuger, J. Shannon, and J. S. Torday
Mesenchymal-epithelial interactions in lung development and repair: are modeling and remodeling the same process?
Am J Physiol Lung Cell Mol Physiol, September 1, 2002; 283(3): L510 - L517.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
N.R. Simler, D.C.J. Howell, R.P. Marshall, N.R. Goldsack, P.S. Hasleton, G.J. Laurent, R.C. Chambers, and J.J. Egan
The rapamycin analogue SDZ RAD attenuates bleomycin-induced pulmonary fibrosis in rats
Eur. Respir. J., June 1, 2002; 19(6): 1124 - 1127.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
G J Bellingan
The pulmonary physician in critical care * 6: The pathogenesis of ALI/ARDS
Thorax, June 1, 2002; 57(6): 540 - 546.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
A E Currie, M Kelly, J R Vyas, H Pandya, D Field, and S Kotecha
Fibroblast mitogenic activity of lung lavage fluid from infants with chronic lung disease of prematurity
Arch. Dis. Child. Fetal Neonatal Ed., May 1, 2002; 86(3): F193 - F197.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
F. Zuo, N. Kaminski, E. Eugui, J. Allard, Z. Yakhini, A. Ben-Dor, L. Lollini, D. Morris, Y. Kim, B. DeLustro, et al.
Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans
PNAS, April 30, 2002; 99(9): 6292 - 6297.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. CONRON, E. ANDREAKOS, P. PANTELIDIS, C. SMITH, H. L. C. BEYNON, R. M. DUBOIS, and B. M. J. FOXWELL
Nuclear Factor-kappa B Activation in Alveolar Macrophages Requires Ikappa B kinase-beta , but Not Nuclear Factor-kappa B Inducing Kinase
Am. J. Respir. Crit. Care Med., April 1, 2002; 165(7): 996 - 1004.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
G.M. Verleden, R.M. du Bois, D. Bouros, M. Drent, A. Millar, J. Muller-Quernheim, G. Semenzato, S. Johnson, G. Sourvinos, D. Olivieri, et al.
Genetic predisposition and pathogenetic mechanisms of interstitial lung diseases of unknown origin
Eur. Respir. J., July 1, 2001; 18(32_suppl): 17S - 29s.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. Kolb, P. J. Margetts, P. J. Sime, and J. Gauldie
Proteoglycans decorin and biglycan differentially modulate TGF-{beta}-mediated fibrotic responses in the lung
Am J Physiol Lung Cell Mol Physiol, June 1, 2001; 280(6): L1327 - L1334.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
F. Takahashi, K. Takahashi, T. Okazaki, K. Maeda, H. Ienaga, M. Maeda, S. Kon, T. Uede, and Y. Fukuchi
Role of Osteopontin in the Pathogenesis of Bleomycin-Induced Pulmonary Fibrosis
Am. J. Respir. Cell Mol. Biol., March 1, 2001; 24(3): 264 - 271.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
G. Krishna, K. Liu, H. Shigemitsu, M. Gao, T. A. Raffin, and G. D. Rosen
PG490-88, a Derivative of Triptolide, Blocks Bleomycin-Induced Lung Fibrosis
Am. J. Pathol., March 1, 2001; 158(3): 997 - 1004.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
H. Imanaka, M. Shimaoka, N. Matsuura, M. Nishimura, N. Ohta, and H. Kiyono
Ventilator-Induced Lung Injury Is Associated with Neutrophil Infiltration, Macrophage Activation, and TGF-{beta}1 mRNA Upregulation in Rat Lungs
Anesth. Analg., February 1, 2001; 92(2): 428 - 436.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
R. P. MARSHALL, G. BELLINGAN, S. WEBB, A. PUDDICOMBE, N. GOLDSACK, R. J. MCANULTY, and G. J. LAURENT
Fibroproliferation Occurs Early in the Acute Respiratory Distress Syndrome and Impacts on Outcome
Am. J. Respir. Crit. Care Med., November 1, 2000; 162(5): 1783 - 1788.
[Abstract] [Full Text]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. C. Savani, Z. Zhou, E. Arguiri, S. Wang, D. Vu, C. C. Howe, and H. M. DeLisser
Bleomycin-induced pulmonary injury in mice deficient in SPARC
Am J Physiol Lung Cell Mol Physiol, October 1, 2000; 279(4): L743 - L750.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
A. Oriente, N. S. Fedarko, S. E. Pacocha, S.-K. Huang, L. M. Lichtenstein, and D. M. Essayan
Interleukin-13 Modulates Collagen Homeostasis in Human Skin and Keloid Fibroblasts
J. Pharmacol. Exp. Ther., March 1, 2000; 292(3): 988 - 994.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
O. Eickelberg, A. Pansky, R. Mussmann, M. Bihl, M. Tamm, P. Hildebrand, A. P. Perruchoud, and M. Roth
Transforming Growth Factor-beta 1 Induces Interleukin-6 Expression via Activating Protein-1 Consisting of JunD Homodimers in Primary Human Lung Fibroblasts
J. Biol. Chem., April 30, 1999; 274(18): 12933 - 12938.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the European Respiratory Society.